QualityStocks would like to highlight Clenergen Corp. (OTCBB: CRGE). Clenergen offers strategic Clean Energy Generation projects to address the requirement for renewable and sustainable supplies of electricity. Clenergen has developed a unique modular system of co-gasification and localized plantation management.
In the company’s news yesterday,
Biomass2Biopower Private Ltd. (“B2B”) announced that it has completed the first stage of its R&D program which is focused on the use of indigenous species of trees as viable sources of feedstock for the production of biomass for gasification power plant projects being implemented by Clenergen Corporation. The program aims to provide validation of the yield, production cycles and agronomy requirements as well as offer diversification to Clenergen’s integrated feedstock supply chain.
“Vanashree” was specifically highlighted in the press release for demonstrating an output of more than 40 tons per acre after 2 years of growth in a variety of soil conditions and relatively low water irrigation requirements. B2B will also develop and produce proprietary Bio pesticides, Bio fertilizers and other high value commodities from the processing of biomass resources. It is estimated that under controlled agronomy practices and fertilization programs, yields will be increased up to 20% on an annual basis.
As previously announced, Clenergen has already reached agreement on the terms to acquire a 1.5MW/Hr biomass power plant in Namakkal, Tamilnadu, which is anticipated to be operational by year end 2009. Once operational, the company will initiate efforts to ramp up the capacity to 10MW/Hr while installing two new biomass power projects: a 16MW/Hr in Tuticorin Tamilnadu and a 64MW/Hr in Karnataka. The total project cost of the new plants has been estimated at US$236 million.
Mark Quinn, CEO of Clenergen, commented, “The wealth of scientific knowledge of the Scientific Advisory Council provides Clenergen the best possible plant science resources for its feedstock cultivation program, along with a variety of alternative indigenous species of trees in India, which can be adopted for specific climatic conditions. B2B will generate revenue from the sale of its bio pesticides and bio fertilizers as well as out sourcing planting materials to third parties for the purpose of cultivating biomass feedstock on behalf of Clenergen Corporation”.
Doctor Ganapathy Arumugam, Managing Director & Group Science Director of EBTI, stated, “Our partnership with Clenergen allows for the commercialization of our classic science expertise in the field of Plant breeding, Agronomy, and Microbiology and can provide a strong foundation for the production and supply of high yielding indigenous planting materials and crop based bio inputs to increase the productivity per unit area for the cultivation of biomass a Non edible feedstock as a source of renewable energy.”
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.
To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.